イスラエル -
英語 -
Ministry of Health
viramune tablets
boehringer ingelheim israel ltd. - nevirapine - tablets - nevirapine 200 mg - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.
イスラエル -
英語 -
Ministry of Health
viramune oral suspension
boehringer ingelheim israel ltd. - nevirapine anhydrous (as hemihydrate) - suspension - nevirapine anhydrous (as hemihydrate) 50 mg / 5 ml - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
viramune 50mg5ml oral suspension
boehringer ingelheim ltd - nevirapine hemihydrate - oral suspension - 10mg/1ml
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
viramune 200mg tablets
boehringer ingelheim ltd - nevirapine - tablet - 200mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
viramune 100mg modified-release tablets
boehringer ingelheim ltd - nevirapine - modified-release tablet - 100mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
viramune 400mg modified-release tablets
boehringer ingelheim ltd - nevirapine - modified-release tablet - 400mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nevirapine 200mg tablets
wockhardt uk ltd - nevirapine - tablet - 200mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nevirapine 200mg tablets
sandoz ltd - nevirapine - tablet - 200mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nevirapine 400mg modified-release tablets
mylan - nevirapine - modified-release tablet - 400mg
マルタ -
英語 -
Medicines Authority
nevirapine accord 400mg prolonged-release tablets
accord healthcare limited - nevirapine, anhydrous - prolonged-release tablet - nevirapine, anhydrous 400 mg - antivirals for systemic use